Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Johnston, D. Mannino, V. Kiri, K. Davis, G. Hagan (Lexington, KY, Research Triangle Park, NC, United States Of America; Greenford, Middlesex, United Kingdom). Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort. Eur Respir J 2007; 30: Suppl. 51, 4020

Member's Comments

No comment yet.

Related content which might interest you: Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Mortality in COPD: role of comorbidities Source: Eur Respir J 2006; 28: 1245-1257 Year: 2006 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 COPD coronary/peripheral vascular disease Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Predictive factors for the incidence of lung cancer (LC) complicated in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Clinical characteristics of postoperative pulmonary infection in lung cancer patients with obstructive pulmonary disease: the trend of microorganisms in bronchial colonization Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006 COPD prevalence is increased in lung cancer, independent of age, sex and smoking history Source: Eur Respir J 2009; 33: 380-386 Year: 2009 Inflammation in COPD: a link to systemic comorbidities Source: Eur Respir Rev 2007; 16: 91-97 Year: 2007 A clinical scoring algorithm to predict all cause mortality in COPD Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Socioeconomic risk factors for COPD and respiratory symptoms in a general population Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Determinants of success Source: Eur Respir J 2011; 38: 1215-1218 Year: 2011 Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly Source: Eur Respir J 2003; 21: 3S-9S Year: 2003 Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes Source: Eur Respir J 2003; 21: 30S-35S Year: 2003 Chronic bronchitis among French adults: high prevalence and underdiagnosis Source: Eur Respir J 2002; 20: 806-812 Year: 2002